Our current understanding of the biological impact of endometrial cancer mtDNA genome mutations and their potential use as a biomarker

Endometrial cancer (EC) is a devastating and common disease affecting women’s health. The NCI Surveillance, Epidemiology, and End Results Program predicted that there would be >66,000 new cases in the United States and >13,000 deaths from EC in 2023, and EC is the sixth most common can...

詳細記述

書誌詳細
主要な著者: Pabitra Khadka, Carolyn K. J. Young, Ravi Sachidanandam, Laurent Brard, Matthew J. Young
フォーマット: 論文
言語:English
出版事項: Frontiers Media S.A. 2024-06-01
シリーズ:Frontiers in Oncology
主題:
オンライン・アクセス:https://www.frontiersin.org/articles/10.3389/fonc.2024.1394699/full